TBPH
NASDAQ · Pharmaceuticals
Theravance Biopharma Inc
$17.03
+0.00 (+0.00%)
Analyst Consensus
Hold
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+46.5% upside
Low Target
$16.23
Average Target
$24.95
High Target
$30.59
Current Price
$17.03
Current
$17.03
$17.03
Target
$24.95
$24.95
$16.23
$24.95 avg
$30.59
Scenario Analysis
Bear Case
$16.23
-4.7%
Low target
Base Case
$24.95
+46.5%
Avg target
Bull Case
$30.59
+79.6%
High target
Risk/Reward
17.0x
Highly favorable
Price in Context
52-Week High
$21.03
-19.0% from high
52-Week Low
$13.08
+30.2% from low
Target vs 52W High
$24.95
+18.6% vs high
Peer Consensus — Pharmaceuticals